Stonepine Capital Management »

Alimera Sciences shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Alimera Sciences (ALIM) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Alimera Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alimera Sciences held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alimera Sciences by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $12M 4.0M 3.10

More positions owned by Stonepine Capital Management

Quidel Corp (QDEL)
Evolus (EOLS)
Amylyx Pharmaceuticals (AMLX)
Adma Biologics (ADMA)
Galapagos Nv- Spons Adr (GLPG)
Alimera Sciences Com New (ALIM)
Maxcyte (MXCT)
Xeris Pharmaceuticals (XERS)
Gamida Cell SHS (GMDA)
Atyr Pharma Com New (LIFE)
Scynexis Com New (SCYX)
Xoma Corp Com New (XOMA)
X4 Pharmaceuticals (XFOR)
Atea Pharmaceuticals (AVIR)
Rezolute Com New (RZLT)

View all positions for Stonepine Capital Management

Top funds holding Alimera Sciences

Caligan Partners
Velan Capital Investment Management
Boothbay Fund Management
Altium Capital Management
Clearline Capital
AIGH Capital Management
Vanguard Group
Morgan Stanley
BlackRock
Geode Capital Management
Ancora Advisors
Bank Of Montreal
Bridgeway Capital Management
Millennium Management
Susquehanna International

View all funds holding Alimera Sciences